Emory participating in Moderna COVID-19 variant vaccine study
Emory is participating in a clinical trial testing a vaccine against the B.1.351 variant of SARS-CoV-2. The first doses were administered at the Hope Clinic of Emory Vaccine Center on Wednesday.
RSSRecent News Releases »
Faculty Opinion »
Afghans want peace. New data show they’re open to a surprising number of options.
COVID variant could mean a brutal March for the US
I've lived in both Americas. Most people everywhere don't want to hate each other
How to reassure Black Americans that the vaccine is safe
How to instill public confidence in a COVID-19 vaccine
Featured Expert »
Andra Gillespie, Politics
Political scientist Andra Gillespie specializes in political mobilization and race and is the author of "The New Black Politician: Cory Booker, Newark and Post-Racial America."
Video »
How customized antibiotic combinations could defeat 'superbugs'
A sneaky form of antibiotic resistance called "heteroresistance" is more widespread than previously appreciated. But tracking heteroresistance might guide the choice of antibiotic combinations that can defeat bacteria regarded as invincible.
Emory in the News »
COVID-19 vaccines are entering uncharted immune territory
The Atlantic, April 15
CDC: About 5,800 'breakthrough infections' reported in fully vaccinated people
NBC News, April 15
Myth or reality? Health experts weigh in on whether ‘herd immunity’ is possible
CNBC, April 14
Feeling anxious because you got the Johnson & Johnson vaccine? Here’s what to do
Los Angeles Times, April 13
- Emory Healthcare CEO Jonathan Lewin in a joint CNN column with Delta CEO Ed Bastian
